
BEAM vs ADMA
$BEAM vs $ADMA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
BEAM vs ADMA: the quick read
- ·BEAM is the larger company by market cap ($2.58B vs $2.04B).
- ·BEAM has been more active on our scanner (164 vs 65 alerts in 30 days).
- ·BEAM has the smaller float (99.3M vs 214.8M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs Biological Products, (No Diagnostic Substances)), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 164 and 65 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 26% of each other on market cap, which makes the rest of this table the interesting part.
- ·BEAM pays a dividend and ADMA does not, which usually means one is being held for income and the other for the move.
- ·ADMA is the one in play today, trading about 5.0x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing BEAM and ADMA on TheDesperateTrader.
- Is BEAM or ADMA the better stock?
- "Better" depends on your goal, and these two are not alike. BEAM is the larger company by market cap ($2.58B vs $2.04B). BEAM has been more active on our scanner (164 vs 65 alerts in 30 days). BEAM has the smaller float (99.3M vs 214.8M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between BEAM and ADMA?
- The differences that matter: they are not in the same business - BEAM is biological products, (no diagnostic substances) and ADMA is biological products, (no diagnostic substances); they are similar in size ($2.58B vs $2.04B); they trade at very different share prices ($24.99 vs $9.10); BEAM sits at 26% of its 52-week range against 14% for ADMA; only BEAM pays a dividend; our scanner flagged BEAM 164 times in the last 30 days against 65 for ADMA. Everything above is measured from the latest completed session and SEC filings.
- Which of BEAM and ADMA is more active right now?
- Right now BEAM is at about 1.2x its normal volume and ADMA is at about 5.0x, so ADMA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading BEAM or ADMA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore BEAM and ADMA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.